Get startedLog in
    Picture of Allergy Therapeutics logo

    AGY — Allergy Therapeutics News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Allergy Therapeutics Enters Final Phase Of Treatment In Phase I/IIA VLP Peanut Protect Trial

    Picture of Allergy Therapeutics logoAllergy Therapeutics
    27/03/2025 07:43
    March 27 (Reuters) - Allergy Therapeutics PLC AGY.L:

ALLERGY THERAPEUTICS PLC: ADVANCES TO FINAL PHASE OF TREATMENT IN PHASE I/IIA VLP PEANUT PROTECT TRIAL

Source text: ID:nRSa3873Ca

Further company coverage: AGY.L

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Allergy Therapeutics

    See all news